TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05327972

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: The investigational medicinal product is incobotulinumtoxinA (XEOMIN®).
Description: Two milliliters of a mixture comprised of XEOMIN® 100 U and saline solution 0.9% will be once injected in the supra-spinatus muscle using ultrasonography guidance.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: PLACEBO
Description: Two milliliters of a saline solution containing an inactive lyophilisate will be once injected in the supra-spinatus muscle using ultrasonography guidance.
Study: NCT05275036

Intervention type: DEVICE
Intervention: early detection test
Description: Blood collection and early detection testing

Intervention type: DEVICE
Intervention: early detection test
Description: Blood collection and early detection testing
Study: NCT06537674

Intervention type: DRUG
Intervention: Trastuzumab intravenous drip/Trastuzumab Subcutaneous Injection
Description: Group A is Trastuzumab intravenous drip,Group B is Trastuzumab Subcutaneous Injection

Intervention type: DRUG
Intervention: Trastuzumab intravenous drip/Trastuzumab Subcutaneous Injection
Description: Group A is Trastuzumab intravenous drip,Group B is Trastuzumab Subcutaneous Injection
Study: NCT05593627

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lithium Carbonate 250 MG Oral Tablet
Description: Patients undergoing heart valve surgery withcardiopulmonary bypass will take 250mg lithium carbonate

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Calcium Carbonate 500 MG Oral Tablet
Description: Patients undergoing heart valve surgery withcardiopulmonary bypass will take 500mg calcium carbonate
Study: NCT06219304

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Multimodal functional training
Description: 40 minutes of multimodal functional training: 20 minutes of aerobic training on treadmill, 10 minutes of dynamic balance training; 10 minutes of functional strength training.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual care
Description: Exercises aimed at improving balance and mobility
Study: NCT05411705

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: rhTPO
Description: rhTPO 300U/kg/d QD, subcutaneous injection applied for 5 days per cycle, total 3 cycles. If the patient's platelet count showed a trend of continuous decline and/or was accompanied by the risk of bleeding during the treatment or after the completion of 5 doses of rhTPO, the investigator judged that rhTPO should be continued for treatment, and rhTPO could be administered subcutaneously at 300U/kg/ day for a maximum of 14 doses per cycle. Discontinue when the absolute platelet count increases by ≥50×10\^9/L or when the platelet count rises to ≥250×10\^9/L.

Intervention type: DRUG
Group type: OTHER
Intervention: Control
Description: Non-rhTPO treatment
Study: NCT05635695

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Free Museum visit
Description: People are tested when they arrive at the museum. Then, they freely visit the different rooms for 45 to 75 minutes. No instructions are given.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cultural pathways App
Description: Cultural pathways in the park of the museum will be proposed to people with a smartphone application that will give directions, cultural and sustainable health contents, points of interest with games and specific information about the pathways (distance, noise level, walkability, practical information). There will be two possible levels: contemplative or active.
Study: NCT05294510

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: STAR Sick Child Job Aid
Description: The STAR Sick Child Job Aid is a modified ICCM protocol that includes the addition of a point-of-care C-reactive protein (CRP) test to inform antibiotic treatment decisions for children presenting with febrile acute respiratory illness who do not have any danger signs. If CRP ≥ 40 mg/L, the village health worker (VHW) will dispense amoxicillin per local guidelines. If CRP \< 40 mg/L, the VHW will advise symptomatic care alone including acetaminophen for fever and additional fluids to maintain hydration.
Study: NCT06420024

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy
Description: See: https://link.springer.com/chapter/10.1007/0-306-48581-8_1
Study: NCT05973565

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Musicokinetic Training
Description: The intervention protocols are either a) synchronous learning format, b) asynchronous remote video- based, and c) control.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Musicokinetic Training
Description: The intervention protocols are either a) synchronous learning format, b) asynchronous remote video- based, and c) control.
Study: NCT05942547

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Diosmin
Description: diosmin 600mg twice daily

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: twice daily
Study: NCT04845763

Intervention type: OTHER
Intervention: FQoR-15 questionnaire
Description: The FQoR-15 questionnaire (French version) consists of 15 questions concerning five domains (the patient's feelings, comfort, pain, dependence on the health care team and psychological well-being). Two to three minutes are required to complete all the questions. If the patient is not able to read the questionnaire himself, a third person can ask the patient the questions orally. In the case of ambulatory surgery, the patient is contacted by telephone to answer the questionnaire. Each item is scored from 0 to 10 and the total score is the sum of the score obtained for each item, i.e. a score from 0 to 150.
Study: NCT05758350

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: home based IOPI swallow training
Description: Use IOPI for tongue and labial muscle resistance training. Conventional training was the same as controlled group.
Study: NCT05814744

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: dexmedetomidine
Description: adding dexmedetomidine as adjuvant with bupivacaine in Ultrasound-guided Intermediate Cervical Plexus Block for Thyroidectomy surgery.

Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: bupivacaine 0.25%
Description: patients will receive bilateral Intermediate Cervical plexus block with 20 ml bupivacaine 0.25%.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: bupivacaine 0.25%
Description: patients will receive bilateral Intermediate Cervical plexus block with 20 ml bupivacaine 0.25%.

Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Thyroidectomy Surgery
Description: surgical removal of all or part of thyroid gland.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Thyroidectomy Surgery
Description: surgical removal of all or part of thyroid gland.

Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Ultrasound-guided intermediate Cervical Plexus Block Technique
Description: the injection of local anesthetic in intermediate cervical plexus nerve block is made between the investing layer of the deep cervical fascia and the prevertebral fascia. Following negative aspiration, 1-2 mL of local anesthetic is injected to confirm the proper injection site.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Ultrasound-guided intermediate Cervical Plexus Block Technique
Description: the injection of local anesthetic in intermediate cervical plexus nerve block is made between the investing layer of the deep cervical fascia and the prevertebral fascia. Following negative aspiration, 1-2 mL of local anesthetic is injected to confirm the proper injection site.
Study: NCT05237804

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Patient component
Description: Video, booklet, website

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Patient component
Description: Video, booklet, website

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Organisational component
Description: Coronarography, CT-scan, anesthesia...

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Organisational component
Description: Coronarography, CT-scan, anesthesia...
Study: NCT05761002

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: the Quadrivalent Vaccine (Gardasil)
Description: • Intralesional injection of the quadrivalent HPV vaccine (Gardasil) at a dose of 0.5ml, into the largest wart at 4-week intervals until complete clearance is achieved or for a maximum of three sessions.
Study: NCT04997291

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexrazoxane
Description: Twelve enrollees will be consecutively assigned to a dosing regimen of 400 mg/m2/dose. The medication will be administered in the operating room 30 minutes prior to starting cardiopulmonary bypass (dose #1), prior to aortic cross clamp removal (dose #2), and on the morning after surgery in the cardiac intensive care unit (dose #3).
Study: NCT05670418

Intervention type: DEVICE
Intervention: Quantitative Electroencephalography
Description: Each qEEG examination of one person lasted about 20 minutes and included two stages: the first-recording of brain waves with eyes closed (5 min), the other with eyes open (5 min)

Intervention type: DEVICE
Intervention: Quantitative Electroencephalography
Description: Each qEEG examination of one person lasted about 20 minutes and included two stages: the first-recording of brain waves with eyes closed (5 min), the other with eyes open (5 min)
Study: NCT04773691

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active rTMS
Description: Two rTMS stimulation sessions spaced 15 minutes apart are delivered daily for 5 consecutive days.~A total of 10 sessions. Stimulation parameters: 10 Hz, 1000 pulses per session, 110% of SM, cortical target: right DLPFC

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Placebo rTMS
Description: Two rTMS stimulation sessions spaced 15 minutes apart are delivered daily for 5 consecutive days.~A total of 10 sessions. Stimulation parameters: delivering a non-significant current at the beginning and end of the stimulation, simulating active stimulation.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Questionnaires
Description: questionnaires for craving assessment: EVA, OCDS, CGI and ADS and signs of physical withdrawal by CIWA

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaires
Description: questionnaires for craving assessment: EVA, OCDS, CGI and ADS and signs of physical withdrawal by CIWA

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Breathalyzer
Description: estimation of blood alcohol level

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Breathalyzer
Description: estimation of blood alcohol level
Study: NCT04983420

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: non-alcoholic Pilsner
Description: intake of 1 L non-alcoholic Pilsner per day for 2 weeks

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: non-alcoholic wheat beer
Description: intake of 1 L non-alcoholic wheat beer per day for 2 weeks

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: apple spritzer
Description: intake of 1 L apple spritzer per day for 2 weeks

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: lemonade
Description: intake of 1 L lemonade per day for 2 weeks
Study: NCT06317168

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Mean awake ambulatory BP measurements
Description: Results from all four arms will be compared to the mean awake ambulatory BP measured on the same arm and started immediately following completion of the testing protocol.

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Mean awake ambulatory BP measurements
Description: Results from all four arms will be compared to the mean awake ambulatory BP measured on the same arm and started immediately following completion of the testing protocol.

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Mean awake ambulatory BP measurements
Description: Results from all four arms will be compared to the mean awake ambulatory BP measured on the same arm and started immediately following completion of the testing protocol.

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Mean awake ambulatory BP measurements
Description: Results from all four arms will be compared to the mean awake ambulatory BP measured on the same arm and started immediately following completion of the testing protocol.
Study: NCT00013013

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Systems Support
Study: NCT05889637

Intervention type: DIAGNOSTIC_TEST
Intervention: Gastric ultrasound
Description: Patient will be scanned first in the supine position and then in the right lateral decubitus position. The ultrasound probe will be placed in a sagittal plane in the epigastric region at the left subcostal margin and then will be moved past the midline in a fan like manner to the right subcostal region. Qualitative and quantitative assessments will be done.

Intervention type: DIAGNOSTIC_TEST
Intervention: Gastric ultrasound
Description: Patient will be scanned first in the supine position and then in the right lateral decubitus position. The ultrasound probe will be placed in a sagittal plane in the epigastric region at the left subcostal margin and then will be moved past the midline in a fan like manner to the right subcostal region. Qualitative and quantitative assessments will be done.
Study: NCT04440657

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self-Assured Parenting program
Description: Parents will receive parenting education for 10 weeks
Study: NCT06479941

Intervention type: OTHER
Intervention: antibiotic treatment
Description: AT: Mother-infant cohort with antibiotic treatment group CS: Mother-infant cohort (Prophylactic antibiotics therapy) ND: Mother-infant cohort (Natural delivery)

Intervention type: OTHER
Intervention: antibiotic treatment
Description: AT: Mother-infant cohort with antibiotic treatment group CS: Mother-infant cohort (Prophylactic antibiotics therapy) ND: Mother-infant cohort (Natural delivery)

Intervention type: OTHER
Intervention: antibiotic treatment
Description: AT: Mother-infant cohort with antibiotic treatment group CS: Mother-infant cohort (Prophylactic antibiotics therapy) ND: Mother-infant cohort (Natural delivery)
Study: NCT05677009

Intervention type: DEVICE
Group type: OTHER
Intervention: BUFEO system
Description: In the BUFEO Condition, the subject will receive oxygen through the BUFEO system.

Intervention type: OTHER
Group type: OTHER
Intervention: Standard of Care
Description: Standard Condition is the baseline apparatus utilized by the subject at the time of enrollment in the study. In the hospital setting, the supplemental oxygen delivery may come from compressed oxygen cylinders or liquid oxygen and is often delivered through a port in the facility wall at the bedside.
Study: NCT05191108

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: mindfulness stres reduction programe
Description: Complaints about PMS and sharing information about these complaints, Practice of breathing focused meditation, mplementation of mindful eating exercises,Raising awareness in daily activities,Teaching the body scanning exercise and repeating this practice during the week with the audio recordings given.Ensuring environmental awareness Ensuring that you live by being aware of the moments experienced during the week, 20 minutes of sitting breathing focused sitting meditation Coping with stress Sharing the experiences of the previous week Implementation of mindful vision practices Explaining the relationship between stress and experienced events.Eating exercises Mindful breathing Ensuring environmental awareness Explaining the importance of thinking about the relationship between stress and their reactions and accepting them without judgment, and sharing the experiences at the end of the day of silence.
Study: NCT05813002

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: standard neural mobilization
Description: is a movement-based intervention aimed at restoring the homeostasis in and around the nervous system.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Distal to proximal neural mobilization
Description: is a distal to proximal movement-based intervention aimed at restoring the homeostasis in and around the nervous system.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: proximal to distal neural mobilization
Description: is a proximal to distal movement-based intervention aimed at restoring the homeostasis in and around the nervous system.
Study: NCT05526287

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dual-Task Training
Description: Dual-task training sessions include; walking on treadmill for 10-30 minutes and half of this walking period participants will perform cognitive tasks, cognitive tasks will be repeated on tandem stance position and single leg stance position other half of the session consists of motor-motor dual task activities and gait training on firm and soft surfaces.~Home exercise program includes lower extremity, core stability and balance exercises and will be performed three times a week.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Home Exercise Program
Description: Home exercise program includes lower extremity, core stability and balance exercises and will be performed three times a week.
Study: NCT06526533

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Liberal Transfusion
Description: Liberal transfusion trigger group (patient receives RBC transfusion if Hb ≤ 90g/L).

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Restrictive Transfusion
Description: Restrictive transfusion trigger group (patient receives RBC transfusion if Hb≤70g/L).
Study: NCT06345911

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Experimental group
Description: The animal characters were shown to the child before the bloodletting procedure. The child was asked to choose one of them and the one chosen by the child was attached to the vacutainer. The child and their parents were taken to the blood collection room. During the bloodletting procedure, the child was asked to focus on the animal character they had chosen.
Study: NCT05296005

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine
Description: Given PO

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Docetaxel
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluorouracil
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Leucovorin
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxaliplatin
Description: Given IV

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiation Therapy
Description: Undergo radiotherapy

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Surgical Procedure
Description: Undergo surgical resection
Study: NCT05181046

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Nanodropper adaptor
Description: The Nanodropper adaptor is a sterile medical device that reduces the size of administered eyedrops by coupling to the original bottle.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Original eyedrop bottle/No Nanodropper
Description: The original eyedrop bottle dispenses standard eyedrops.
Study: NCT05592171

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Microwave ablation + Occlusafe + DEB-TACE
Description: Microwave ablation (MW) is based on the production of heating by friction given by the oscillation of water molecules.~After positioning and inflating the Occlusafe® balloon in the artery that connects to the HCC nodule, the blood flow tends to go preferentially to the HCC nodule compared to the healthy liver. The increase in the water content in the tumor area, after using the Occlusafe® balloon microcatheter, could increase the ability of microwave ablation to cover larger volumes in a shorter time.~The delivery of drug-releasing microspheres (DEB-TACE) at the same time as microwave ablation, could promote the arrest of tumor growth.

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Microwave ablation + Occlusafe
Description: Microwave ablation (MW) is based on the production of heating by friction given by the oscillation of water molecules.~After positioning and inflating the Occlusafe® balloon in the artery that connects to the HCC nodule, the blood flow tends to go preferentially to the HCC nodule compared to the healthy liver. The increase in the water content in the tumor area, after using the Occlusafe® balloon microcatheter, could increase the ability of microwave ablation to cover larger volumes in a shorter time.

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Microwave ablation + DEB-TACE
Description: Microwave ablation (MW) is based on the production of heating by friction given by the oscillation of water molecules.~The delivery of drug-releasing microspheres (DEB-TACE) at the same time as microwave ablation, could promote the arrest of tumor growth.
Study: NCT06278480

Intervention type: DEVICE
Intervention: MegaCarti®
Description: Medical devices containing allogeneic cartilage

Intervention type: PROCEDURE
Intervention: microfracture
Description: microfracture

Intervention type: PROCEDURE
Intervention: microfracture
Description: microfracture
Study: NCT06551792

Intervention type: OTHER
Intervention: Effect of Serum Magnesium Level on the Success of Transforaminal Epidural Steroid Injection
Description: Effect of Serum Magnesium Level on the Success of Transforaminal Epidural Steroid Injection
Study: NCT04640415

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Active Alarms
Description: Intervention consists of actively alerting staff personnel if physiologic vital signs, deviates from certain thresholds for more than a set duration. Continuous vital sign data will also be available to clinical staff.
Study: NCT05531565

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Litifilimab
Description: Administered as specified in the treatment arm.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Litifilimab
Description: Administered as specified in the treatment arm.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administered as specified in the treatment arm.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administered as specified in the treatment arm.
Study: NCT04552795

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 3TC
Description: 12 subjects will be administered 3TC, 300mg once daily, via an oral tablet for 24 weeks.
Study: NCT05010265

Intervention type: OTHER
Intervention: Clinician Questionnaire
Description: Surveys will serve to identify preferences, expectations and concerns among clinicians and researchers surrounding data-sharing of uncertain diagnostic data generated through investigative neurotechnologies which will then be systematically evaluated.

Intervention type: OTHER
Intervention: Semi Structured Interviews
Description: Semi-structured interviews will further serve to identify preferences, expectations and concerns among patients, surrogates, clinicians and researchers surrounding data-sharing of uncertain diagnostic data generated through these investigative neurotechnologies which will then be systematically evaluated.